Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The quail mesonephros: a new model for renal senescence?
Nacher V, Carretero A, Navarro M, Armengol C, Llombart C, Rodríguez A, Herrero-Fresneda I, Ayuso E, Ruberte J. Nacher V, et al. Among authors: armengol c. J Vasc Res. 2006;43(6):581-6. doi: 10.1159/000096076. Epub 2006 Oct 6. J Vasc Res. 2006. PMID: 17028443
Morphological characterization of pecteneal hyalocytes in the developing quail retina.
Llombart C, Nacher V, Ramos D, Luppo M, Carretero A, Navarro M, Melgarejo V, Armengol C, Rodríguez-Baeza A, Mendes-Jorge L, Ruberte J. Llombart C, et al. Among authors: armengol c. J Anat. 2009 Sep;215(3):280-91. doi: 10.1111/j.1469-7580.2009.01117.x. Epub 2009 Jun 29. J Anat. 2009. PMID: 19566699 Free PMC article.
Physiologic Effects of Housing Rats in Metabolic Cages.
Giral M, Armengol C, Gavaldà A. Giral M, et al. Among authors: armengol c. Comp Med. 2022 Oct 1;72(5):298-305. doi: 10.30802/AALAS-CM-22-000026. Epub 2022 Sep 20. Comp Med. 2022. PMID: 36127131 Free PMC article.
Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases.
Erra M, Taltavull J, Gréco A, Bernal FJ, Caturla JF, Gràcia J, Domínguez M, Sabaté M, Paris S, Soria S, Hernández B, Armengol C, Cabedo J, Bravo M, Calama E, Miralpeix M, Lehner MD. Erra M, et al. Among authors: armengol c. ACS Med Chem Lett. 2016 Nov 30;8(1):118-123. doi: 10.1021/acsmedchemlett.6b00438. eCollection 2017 Jan 12. ACS Med Chem Lett. 2016. PMID: 28105286 Free PMC article.
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
Aguilar N, Mir M, Grima PM, López M, Segarra V, Esteban L, Moreno I, Godessart N, Tarrasón G, Domenech T, Vilella D, Armengol C, Córdoba M, Sabaté M, Casals D, Domínguez M. Aguilar N, et al. Among authors: armengol c. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7672-6. doi: 10.1016/j.bmcl.2012.09.110. Epub 2012 Oct 11. Bioorg Med Chem Lett. 2012. PMID: 23141913
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
Hebert AA, Flohr C, Hong HC, Irvine AD, Pierce E, Elmaraghy H, Pillai S, Dawson Z, Chen S, Armengol C, Siegfried E, Weidinger S. Hebert AA, et al. Among authors: armengol c. J Dermatolog Treat. 2024 Dec;35(1):2324833. doi: 10.1080/09546634.2024.2324833. Epub 2024 May 12. J Dermatolog Treat. 2024. PMID: 38735650 Free article. Clinical Trial.
63 results